Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma. Issue 2 (1st February 2023)

Record Type:: Journal Article
Title:: Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma. Issue 2 (1st February 2023)
Main Title:: Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma
Authors:: Tan, Aaron C.
Kobayashi, Keigo
Saw, Stephanie P.L.
Tan, Daniel S.W.
Lim, Darren Wan-Teck
Abstract:
Is Part Of:: Expert review of anticancer therapy. Volume 23:Issue 2(2023)
Journal:: Expert review of anticancer therapy
Issue:: Volume 23:Issue 2(2023)
Issue Display:: Volume 23, Issue 2 (2023)
Year:: 2023
Volume:: 23
Issue:: 2
Issue Sort Value:: 2023-0023-0002-0000
Page Start:: 117
Page End:: 120
Publication Date:: 2023-02-01
Subjects:: EGFR mutation -- lung cancer -- immunotherapy -- non-small cell lung cancer
Cancer -- Treatment -- Periodicals
616.99406
Journal URLs:: http://informahealthcare.com ↗
http://www.future-drugs.com/loi/era ↗
DOI:: 10.1080/14737140.2023.2152795 ↗
Languages:: English
ISSNs:: 1473-7140
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002982
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 26115.xml